These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Factors which influence phosphorus removal in hemodialysis]. Gallar P, Ortiz M, Ortega O, Rodríguez I, Seijas V, Carreño A, Oliet A, Vigil A. Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879 [Abstract] [Full Text] [Related]
8. Hemodiafiltration for vancomycin overdose in a patient with end-stage renal failure. Akil IO, Mir S. Pediatr Nephrol; 2001 Dec; 16(12):1019-21. PubMed ID: 11793092 [Abstract] [Full Text] [Related]
9. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study. Soto Guerrero Y, Hernández Castillo R, Santiago E, Ramírez Yuch N, Jaume Anselmi F, Jové R, Flores R, Lebrón R, Ramírez Rivera J. Bol Asoc Med P R; 2012 Dec; 104(3):10-4. PubMed ID: 23156886 [Abstract] [Full Text] [Related]
10. An improved method of vancomycin administration to dialysis patients. Edell LS, Westby GR, Gould SR. Clin Nephrol; 1988 Feb; 29(2):86-7. PubMed ID: 3359698 [Abstract] [Full Text] [Related]
14. Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk: a pilot study. Muñoz RI, Montenegro J, Salcedo A, Gallardo I, Martínez I, Quintanilla N, Saracho R, Lekuona I. Hemodial Int; 2008 Jan; 12(1):108-13. PubMed ID: 18271851 [Abstract] [Full Text] [Related]